COMP-angiopoietin-1 recovers molecular biomarkers of neuropathy and improves vascularisation in sciatic nerve of ob/ob mice

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Kosacka, Joanna ^a   Nowicki, Marcin ^a   Klöting, Nora ^a   Kern, Matthias ^a   Stumvoll, Michael ^a   Bechmann, Ingo ^a   Serke, Heike ^a   Blüher, Matthias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; BIOLOGICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN ANGIOPOIETIN 1; CHOLESTEROL; CONNEXIN 26; CONNEXIN 32; CONNEXIN 43; GLUCOSE; GROWTH ASSOCIATED PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN NEUROFILAMENT 68; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANGIOPOIETIN RECEPTOR; COMP ANG1 FUSION PROTEIN; COMP-ANG1 FUSION PROTEIN; GAP JUNCTION PROTEIN; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MOUSE; MYELINATED NERVE; NERVE REGENERATION; NEUROPATHY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCIATIC NERVE; T LYMPHOCYTE; TREATMENT RESPONSE; UPREGULATION; VASCULARIZATION; ANIMAL; BLOOD; CELL JUNCTION; DIABETIC NEUROPATHY; DRUG EFFECT; METABOLISM; MOUSE MUTANT; NERVE CELL; PHOSPHORYLATION; ULTRASTRUCTURE;

MUS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL; CONNEXINS; DIABETIC NEUROPATHIES; GAP JUNCTIONS; MALE; MICE; MICE, KNOCKOUT; NERVE REGENERATION; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, TIE-2; RECOMBINANT FUSION PROTEINS; SCIATIC NERVE;

EID: 84857839482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032881     Document Type: Article

References (50)

1. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA, (2002) Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats. Diabetes Metab Res Rev 18: 49-56.
2. Kim HC, Cho YJ, Ahn CW, Park KS, Kim JC, et al. (2009) Nerve growth factor and expression of its receptors in patients with diabetic neuropathy. Diabet Med 26: 1228-1234.
3. McLean WG, (1997) The role of axonal cytoskeleton in diabetic neuropathy. Neurochem Res 22: 951-956.
4. Pitre DA, Seifert JL, Bauer JA, (2001) Perineurium inflammation and altered connexin isoform expression in a rat model of diabetes related peripheral neuropathy. Neurosci Lett 303: 67-71.
5. Smith AG, Singleton JR, (2008) Impaired glucose tolerance and neuropathy. Neurologist 14: 23-29 Review.
6. King RH, (2001) The role of glycation in the pathogenesis of diabetic polyneuropathy. Mol Pathol 54: 400-408.
7. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M, (2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108-111.
8. Tahrani AA, Askwith T, Stevens MJ, (2010) Emerging drugs for diabetic neuropathy. Expert Opin Emerg Drugs 15: 661-683.
9. Drel VR, Mashtalir N, Ilnytska O, Shin J, Li F, et al. (2006) The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 55: 3335-3343.
10. Haluzik M, Colombo C, Gavrilova O, Chua S, Wolf N, et al. (2004) Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 145: 3258-3264.
11. Nowicki M, Kosacka J, Blüher M, Serke H, Spanel-Borowski K, (2012) Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, for peripheral diabetic polyneuropathy and the metabolic syndrome. J Neurosci Res 90: 122-131.
12. Chen X, Fu W, Tung CE, Ward NL, (2009) Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, beta1-integrin-dependent manner. Neurosci Res 64: 348-354.
13. Kosacka J, Figiel M, Engele J, Hilbig H, Majewski M, et al. (2005) Angiopoietin-1 promotes neurite outgrowth from dorsal root ganglion cells positive for Tie-2 receptor. Cell Tissue Res 320: 11-19.
14. Valable S, Bellail A, Lesne S, Liot G, Mackenzie ET, et al. (2003) Angiopoietin-1-induced PI3-kinase activation prevents neuronal apoptosis. FASEB J 17: 443-5.
15. Ward NL, Putoczki T, Mearow K, Ivanco TL, Dumont DJ, (2005) Vascular-specific growth factor angiopoietin 1 is involved in the organization of neuronal processes. J Comp Neurol 482: 244-256.
16. Cho CH, Kammerer RA, Lee HJ, Yasunaga K, Kim KT, et al. (2004) Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci U S A 101: 5553-5558.
17. Ward NL, Dumont DJ, (2002) The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 13: 19-27.
18. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, et al. (2000) Vascular-specific growth factors and blood vessel formation. Review. Nature 407: 242-248.
19. Chen JX, Stinnett A, (2008) Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arterioscler Thromb Vasc Biol 28: 1606-1613.
20. Patel JI, Hykin PG, Gregor ZJ, Boulton M, Cree IA, (2005) Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol 89: 480-483.
21. Park BH, Song KJ, Yoon SJ, Park HS, Jang KY, (2011) Acceleration of spinal fusion using COMP-angiopoietin 1 with allografting in a rat model. Bone [Epub ahead of print].
22. Jung YJ, Kim DH, Lee AS, Lee S, Kang KP, et al. (2009) Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury. Am J Physiol Renal Physiol 297: F952-960.
23. Scott JN, Clark AW, Zochodne DW, (1999) Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons. Brain 122: 2109-2118.
24. Nagaoka T, Oyamada M, Okajima S, Takamatsu T, (1999) Differential expression of gap junction proteins connexin26, 32, and 43 in normal and crush-injured rat sciatic nerves. Close relationship between connexin43 and occludin in the perineurium. J Histochem Cytochem 47: 937-948.
25. Shimizu F, Sano Y, Haruki H, Kanda T, (2011) Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and vascular endothelial growth factor (VEGF) by pericytes. Diabetologia 54: 1517-1526.
26. Chandross KJ, (1998) Nerve injury and inflammatory cytokines modulate gap junctions in the peripheral nervous system. Glia 24: 21-31 Review.
27. Empl M, Renaud S, Erne B, Fuhr P, Straube A, et al. (2001) TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56: 1371-1377.
28. Sacerdote P, Franchi S, Trovato AE, Valsecchi AE, Panerai AE, et al. (2008) Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Neurosci Lett 436: 210-213.
29. Hotamisligil GS, Shargill NS, Spiegelman BM, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
30. Leung L, Cahill CM, (2010) TNF-alpha and neuropathic pain-a review. Neuroinflammation 7: 27 Review.
31. Giannini C, Dyck PJ, (1995) Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 37: 498-504.
32. Hobson MI, (2002) Increased vascularisation enhances axonal regeneration within an acellular nerve conduit. Ann R Coll Surg Engl 84: 47-53.
33. Nukada H, (1988) Post-traumatic endoneurial neovascularization and nerve regeneration: a morphometric study. Brain Res 449: 89-96.
34. Read DE, Gorman AM, (2009) Involvement of Akt in neurite outgrowth. Cell Mol Life Sci 66: 2975-84 Review.
35. Joussen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, et al. (2002) Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 160: 1683-1693.
36. Lee S, Kim W, Moon SO, Sung MJ, Kim DH, et al. (2007) Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol Dial Transplant 22: 396-408.
37. Hoffman PN, Cleveland DW, Griffin JW, Landes PW, Cowan NJ, et al. (1987) Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci U S A 84: 3472-3476.
38. Zochodne DW, Verge VM, Cheng C, Sun H, Johnston J, (2001) Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. Brain 124: 2319-34.
39. Lee KN, Seo MC, Bae IH, Oh SH, Jang WG, et al. (2010) COMP-Ang1, a variant of angiopoietin 1, inhibits serum-deprived apoptosis of mesenchymal cells via PI3K/Akt and mitogen-activated protein kinase pathways. Pharmacology 86: 327-335.
40. Sung HK, Kim YW, Choi SJ, Kim JY, Jeune KH, et al. (2009) COMP-angiopoietin-1 enhances skeletal muscle blood flow and insulin sensitivity in mice. Am J Physiol Endocrinol Metab 297: E402-409.
41. Murashov AK, Haq IU, Hill C, Park E, Smith M, et al. (2001) Crosstalk between p38, Hsp25 and Akt in spinal motor neurons after sciatic nerve injury. Mol Brain Res 93: 199-208.
42. Yamazaki T, Sabit H, Oya T, Ishii Y, Hamashima T, et al. (2009) Activation of MAP kinases, Akt and PDGF receptors in injured peripheral nerves. J Peripher Nerv Syst 14: 165-176.
43. Markus A, Zhong J, Snider WD, (2002) Raf and akt mediate distinct aspects of sensory axon growth. Neuron 35: 65-76.
44. Namikawa K, Honma M, Abe K, Takeda M, Mansur K, et al. (2000) Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci 20: 2875-2886.
45. Weerasuriya A, Mizisin AP, (2011) The blood-nerve barrier: structure and functional significance. Methods Mol Biol 686: 149-173.
46. Retamal MA, Froger N, Palacios-Prado N, Ezan P, Sáez PJ, et al. (2007) Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci 27: 13781-13792.
47. Said G, Lacroix C, Lozeron P, Ropert A, Planté V, et al. (2003) Inflammatory vasculopathy in multifocal diabetic neuropathy. Brain 126: 376-385.
48. Said G, (2007) Diabetic neuropathy-a review. Nat Clin Pract Neurol 3: 331-340 Review.
49. Yasuda H, Dyck PJ, (1987) Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 37: 20-28.
50. Lindström P, (2007) The physiology of obese-hyperglycemic mice [ob/ob mice]. ScientificWorld Journal 7: 666-685 Review.